Hope Radiation Cancer Center

2900 Hwy 77, Lynn Haven, FL 32444    Phone: 850-481-1687   Fax: 850-481-0761

RTOG Studies


    1.   RTOG 0837; Conventional chemoradiation & Temozolomide plus Cediranib vs. conventional chemoradiation & Temozolomide plus placebo for newly diagnosed Glioblastoma

Head & Neck

    1.   RTOG 0920; Phase III study of post op IMRT +/- Cetuximab for locally advanced resected head and neck cancer


    1.   RTOG 0617: Stage IIIA/IIIB NSCL ca; Must be inoperable and unresectable; exclude pt w/N3 supraclavicular disease
     2.   1RTOG 0937: Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extra cranial irradiation for extensive disease small cell lung cancer (ED-SCLC)


     1.   RTOG 0848; Phase III trial evaluating both Erlotinib and chemoradiation as adjuvant for patients with resected head of pancreas


    1.   RTOG 0815: A phase III randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer
    2.   RTOG 0534: A phase III trial of short term androgen deprivation with pelvic lymph node or prostate bed only radiotherapy (SPPORT) in prostate cancer patients with a rising PSA after radical prostatectomy.


    1.   RTOG 0921; A phase II study of postoperative IMRT w/concurrent Cisplatin & Bevacizumab followed by Carboplatin & Paclitaxel for pt w/ endometrial cancer
    2.   GOG 0258; Randomized phase III trial of Cisplatin tumor volume directed irradiation followed by Carboplatin & Paclitaxel vs. Carboplatin & Paclitaxel for optimally debulked advanced endometrial cancer. Stage III or IVA endometrial carcinoma with no spread outside pelvis. Surgery: hysterectomy w/bilateral salpingo-opphorectormy